Murdock Hunter R. (CIK 1934008) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-06-23). Recent activity: Buy AXSM (7,500 shares), Sell AXSM (7,500 shares), Buy AXSM (6,014 shares), Sell AXSM (6,014 shares), Buy AXSM (7,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-23 | Axsome Therapeutics, Inc. (AXSM) | General Counsel | Buy | 7,500 | $224,325 |
| 2025-06-23 | Axsome Therapeutics, Inc. (AXSM) | General Counsel | Sell | 7,500 | $768,525 |
| 2025-06-23 | Axsome Therapeutics, Inc. (AXSM) | General Counsel | Buy | 6,014 | $179,879 |
| 2025-06-23 | Axsome Therapeutics, Inc. (AXSM) | General Counsel | Sell | 6,014 | $602,122 |
| 2025-06-18 | Axsome Therapeutics, Inc. (AXSM) | General Counsel | Buy | 7,500 | $224,325 |
| 2025-06-18 | Axsome Therapeutics, Inc. (AXSM) | General Counsel | Sell | 7,500 | $768,150 |
| 2025-06-18 | Axsome Therapeutics, Inc. (AXSM) | General Counsel | Buy | 7,500 | $224,325 |
| 2025-06-18 | Axsome Therapeutics, Inc. (AXSM) | General Counsel | Sell | 7,500 | $751,950 |
| 2025-06-18 | Axsome Therapeutics, Inc. (AXSM) | General Counsel | Buy | 7,500 | $224,325 |
| 2025-06-18 | Axsome Therapeutics, Inc. (AXSM) | General Counsel | Sell | 7,500 | $756,750 |
Source: SEC Form 4 filings · as of 2025-06-23